DECIMMUNE THERAPEUTICS INC

Profile

Company Names

DECIMMUNE THERAPEUTICS INC

Addresses

C/O HEALTHCARE VENTURES, 47 THORNDIKE ST. SUITE B1-1, CAMBRIDGE, MA 02141

C/O HEALTHCARE VENTURES, 55 CAMBRIDGE PARKWAY, SUITE 301, CAMBRIDGE, MA 02142

Phone Numbers

617-278-6655

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$2,814,937.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2013-01-03 
$1,749,999.00 
$2,249,999.00 
$500,000.00 
Equity 
1
2010-09-03 
$1,064,938.00 
$1,064,938.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
C. 
CARROLL, PH.D. 
DIRECTOR
DECIMMUNE THERAPEUTICS INC
RICHARD 
S. 
FOEMMEL, PH.D. 
DIRECTOR
DECIMMUNE THERAPEUTICS INC
LEWIS 
 
GEFFEN 
EXECUTIVE OFFICER
DECIMMUNE THERAPEUTICS INC   |  TARSA THERAPEUTICS, INC.   |  SYNLOGIC, INC.   |  AMBIO HOLDINGS, INC.   |  LUMEN LABS INC.   |  OPSONIX, INC.   |  SYNLOGIC, LLC   |  AURA BIOSCIENCES, INC.   |  UNRAVEL BIOSCIENCES, INC.
LEWIS 
J. 
GEFFEN 
EXECUTIVE OFFICER
DECIMMUNE THERAPEUTICS INC
CHRISTOPHER 
K. 
MIRABELLI, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
DECIMMUNE THERAPEUTICS INC
JANIS 
C. 
NAEVE, PH.D. 
DIRECTOR
DECIMMUNE THERAPEUTICS INC
HAROLD 
R. 
WERNER 
DIRECTOR
XENCOR INC   |  STEMGENT INC   |  PROMEDIOR INC   |  STEMGENT, INC.   |  DECIMMUNE THERAPEUTICS INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-01-16
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2013-01-03 
2010-09-17
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2010-09-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#